{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:49:09Z","timestamp":1773017349301,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Cathepsin K (catK) expression is increased in cartilage, bone and synovium during osteoarthritis (OA). To study the role of catK expression and elevated cathepsin activity in the synovium on cartilage destruction in established OA, we overexpressed cystatin C (cysC), a natural cysteine protease inhibitor, in the synovium of rabbit OA joints.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The ability of cysC to inhibit activity of cathepsins in rabbit OA synovium lysates was tested <jats:italic>in vitro<\/jats:italic> using protease activity assay. <jats:italic>In vivo<\/jats:italic>, the tissue localization of recombinant adeno-associated virus (rAAV) with <jats:italic>LacZ<\/jats:italic> gene after intra-articular injection was determined by \u03b2-galactosidase staining of rabbit joints 4 weeks later. To inhibit cathepsin activity in the synovium, a rAAV2-encoding cysC was delivered intra-articularly into rabbit joints 4 weeks after OA was induced by anterior cruciate ligament transection (ACLT). Seven weeks postinjection, endogenous catK and cysC levels as well as the vector-derived cysC expression in the synovium of normal and OA joints were examined by RNA quantification. Synovial cathepsin activity and catK, catB and catL protein levels were determined by activity and Western blot analyses, respectively. Synovitis and cartilage degradation were evaluated by histopathological scoring.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p><jats:italic>In vitro<\/jats:italic>, the ability of cysC to efficiently inhibit activity of purified catK and OA-induced cathepsins in rabbit synovial lysates was demonstrated. <jats:italic>In vivo<\/jats:italic>, the intra-articular delivery of rAAV2\/LacZ showed transduction of mostly synovium. Induction of OA in rabbit joints resulted in fourfold increase in catK mRNA compared to sham controls while no change was detected in endogenous cysC mRNA levels in the synovium. Protein levels for catK, catB and catL were also increased in the synovium with a concomitant fourfold increase in cathepsin activity. Joints treated with rAAV2\/cysC showed both detection of vector genomes and vector-derived cysC transcripts in the synovium. Production of functional cysC by the vector was demonstrated by complete block of cathepsin activity in the synovium. However, this did not decrease synovitis, bone sclerosis or progression of cartilage degradation.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Increased production of natural cathepsin inhibitor, cysC, in OA synovium does not alleviate synovitis or cartilage pathology during a preexisting OA.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-015-0519-3","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T10:44:05Z","timestamp":1421318645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Overexpression of cystatin C in synovium does not reduce synovitis or cartilage degradation in established osteoarthritis"],"prefix":"10.1186","volume":"17","author":[{"given":"Sirkka","family":"Kyostio-Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Piraino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Berthelette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nance","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Serriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Bendele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen","family":"Sookdeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria L","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,16]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2005.01.013","volume":"35","author":"P Sarzi-Puttini","year":"2005","unstructured":"Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini A, Zaninelli A, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum. 2005;35:1\u201310.","journal-title":"Semin Arthritis Rheum"},{"key":"519_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/ar2304","volume":"9","author":"Y Rengel","year":"2007","unstructured":"Rengel Y, Ospelt C, Gay S. Proteases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther. 2007;9:221\u201331.","journal-title":"Arthritis Res Ther"},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/art.10185","volume":"46","author":"YT Konttinen","year":"2002","unstructured":"Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J, Liljestr\u00f6m M, et al. Acidic cysteine endoproteinase Cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum. 2002;46:953\u201360.","journal-title":"Arthritis Rheum"},{"key":"519_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/1529-0131(199808)41:8<1378::AID-ART6>3.0.CO;2-J","volume":"41","author":"G Keyszer","year":"1998","unstructured":"Keyszer G, Redlich A, Haup H\u00e4upl T, Zacher J, Sparmann M, Engeth\u00fcm U, et al. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum. 1998;41:1378\u201387.","journal-title":"Arthritis Rheum"},{"key":"519_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/03009740701340172","volume":"36","author":"E Solau-Gervais","year":"2007","unstructured":"Solau-Gervais E, Zerimech F, Lemaire R, Fontaine C, Huet G, Flipo RM. Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 2007;36:373\u20137.","journal-title":"Scand J Rheumatol"},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.192.6.789","volume":"192","author":"A Punturieri","year":"2002","unstructured":"Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathesin K-deficient human macrophages. J Exp Med. 2002;192:789\u201399.","journal-title":"J Exp Med"},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/art.10114","volume":"46","author":"WS Hou","year":"2002","unstructured":"Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, et al. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum. 2002;46:663\u201374.","journal-title":"Arthritis Rheum"},{"key":"519_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biochi.2007.08.011","volume":"90","author":"F Lecaille","year":"2008","unstructured":"Lecaille F, Br\u00f6mme D, Lalmanach G. Biochemical properties and regulation of cathepsin K activity. Biochimie. 2008;90:208\u201326.","journal-title":"Biochimie"},{"key":"519_CR9","doi-asserted-by":"publisher","first-page":"12517","DOI":"10.1074\/jbc.271.21.12517","volume":"271","author":"MJ Bossard","year":"1996","unstructured":"Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, et al. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation and substrate identification. J Biol Chem. 1996;271:12517\u201324.","journal-title":"J Biol Chem"},{"key":"519_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/rheumatology\/36.7.735","volume":"36","author":"R Lemaire","year":"1997","unstructured":"Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Duquesnoy B, et al. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol. 1997;36:735\u201343.","journal-title":"Br J Rheumatol"},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2353\/ajpath.2008.070494","volume":"173","author":"VM Dejica","year":"2008","unstructured":"Dejica VM, Mort JS, Laverty S, Percival MD, Antoniou J, Zukor DJ, et al. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. Am J Pathol. 2008;173:161\u20139.","journal-title":"Am J Pathol"},{"key":"519_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2009.06.040","volume":"408","author":"JP Bao","year":"2009","unstructured":"Bao JP, Chen WP, Feng J, Zhao J, Shi ZL, Huang K, et al. Variation patterns of two degradation enzyme systems in articular cartilage in different stages of osteoarthritis: regulation by dehydroepiandrosterone. Clin Chim Acta. 2009;408:1\u20137.","journal-title":"Clin Chim Acta"},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/ard.2002.004671","volume":"63","author":"JP Morko","year":"2004","unstructured":"Morko JP, S\u00f6destr\u00f6m M, S\u00e4\u00e4m\u00e4nen AMK, Salminen HJ, Vuorio EI. Up-regulation of Cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis. 2004;63:649\u201355.","journal-title":"Ann Rheum Dis"},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.joca.2008.07.017","volume":"17","author":"T Vinardell","year":"2009","unstructured":"Vinardell T, Dejica MD, Poole AR, Mort JS, Richard H, Laverty S. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis. Osteoarthritis Cartilage. 2009;17:375\u201383.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR15","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1002\/art.21423","volume":"52","author":"J Morko","year":"2005","unstructured":"Morko J, Kiviranta R, Joronen K, S\u00e4\u00e4m\u00e4nen AM, Vuorio E, Salminen-Mankonen H. Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing Cathepsin K. Arthritis Rheum. 2005;52:3713\u20137.","journal-title":"Arthritis Rheum"},{"key":"519_CR16","first-page":"235","volume":"11","author":"E Kozawa","year":"2012","unstructured":"Kozawa E, Nishida Y, Cheng XW, Urakawa H, Arai E, Futamura N, et al. Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis. Clin Exp Med. 2012;11:235\u201343.","journal-title":"Clin Exp Med"},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.joca.2009.03.015","volume":"17","author":"JR Conner","year":"2009","unstructured":"Conner JR, LePage C, Swift BA, Yamashita D, Bendele AM, Maul D, et al. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis. Osteoarthritis Cartilage. 2009;17:1236\u201343.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.bone.2012.03.025","volume":"50","author":"T Hayami","year":"2012","unstructured":"Hayami T, Zhuo Y, Wesolowski GA, Picarski M, Duong LT. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone. 2012;50:1250\u20139.","journal-title":"Bone"},{"key":"519_CR19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.joca.2010.07.014","volume":"18","author":"JJ McDougall","year":"2010","unstructured":"McDougall JJ, Schuelert N, Bowyer J. Cathepsin K inhibition reduces CTXII levels and joint pain in the guinea pig model of spontaneous osteoarthritis. Osteoarthritis Cartilage. 2010;18:1355\u20137.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/art.24718","volume":"60","author":"D Takahashi","year":"2009","unstructured":"Takahashi D, Iwasaki N, Kon S, Matsui Y, Majima T, Minami A, et al. Down-regulation of cathepsin K in synovium leads to progression of osteoarthritis in rabbits. Arthritis Rheum. 2009;60:2372\u201380.","journal-title":"Arthritis Rheum"},{"key":"519_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","volume":"51","author":"CR Scanzell","year":"2012","unstructured":"Scanzell CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249\u201357.","journal-title":"Bone"},{"key":"519_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","volume":"13","author":"X Ayral","year":"2005","unstructured":"Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005;13:361\u20137.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/BJ20030468","volume":"375","author":"F Lecaille","year":"2003","unstructured":"Lecaille F, Weidauer E, Juliano MA, Br\u00f6mme D, Lalmanach G. Probing cathepsin K activity with a selective substrate spanning its active site. Biochem J. 2003;375:307\u201312.","journal-title":"Biochem J"},{"key":"519_CR24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1042\/bj3300833","volume":"330","author":"RW Mason","year":"1998","unstructured":"Mason RW, Sol-Church K, Abrahamson M. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Biochem J. 1998;330:833\u20138.","journal-title":"Biochem J"},{"key":"519_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","volume":"9","author":"RJ Ziegler","year":"2004","unstructured":"Ziegler RJ, Lonning SM, Armentano D, Li C, Souza DW, Cherry M, et al. AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice. Mol Ther. 2004;9:231\u201340.","journal-title":"Mol Ther"},{"key":"519_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","volume":"76","author":"JE Rabinowitz","year":"2002","unstructured":"Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol. 2002;76:791\u2013801.","journal-title":"J Virol"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gt.2008.115","volume":"16","author":"P Pechan","year":"2009","unstructured":"Pechan P, Rubin H, Lukason M, Ardinger J, DuFresne E, Hauswirth WW, et al. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther. 2009;16:10\u20136.","journal-title":"Gene Ther"},{"key":"519_CR28","unstructured":"ImageJ, Image Processing and Analysis in Java. http:\/\/rsb.info.nih.gov\/ij. Accessed November 10, 2015"},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.joca.2012.07.004","volume":"20","author":"P Li","year":"2012","unstructured":"Li P, Raitcheva D, Hawes M, Moran N, Yu X, Wang F, et al. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms. Osteoarthritis Cartilage. 2012;20:1336\u201346.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1063-4584(97)80039-8","volume":"5","author":"DG Chang","year":"1997","unstructured":"Chang DG, Iverson EP, Schinagi RM, Sonoda M, Amiel D, Coutts RD, et al. Quantitation and localization of cartilage degeneration following the induction of osteoarthritis in the rabbit knee. Osteoarthritis Cartilage. 1997;5:357\u201372.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.joca.2010.05.030","volume":"18","author":"N Gerwin","year":"2010","unstructured":"Gerwin N, Bendele A, Glasson S, Carlson CS. The OARSI histopathology initiative \u2013 recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage. 2010;18:24\u201334.","journal-title":"Osteoarthritis Cartilage"},{"key":"519_CR32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2144\/97226bm16","volume":"22","author":"C Reno","year":"1997","unstructured":"Reno C, Marchuk L, Sciore P, Frank CB, Hart DA. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissue. Biotechniques. 1997;22:1082\u20136.","journal-title":"Biotechniques"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/jhered\/esn083","volume":"100","author":"DA Triant","year":"2009","unstructured":"Triant DA, Whitehead A. Simultaneous extraction of high-quality RNA and DNA from small tissue samples. J Hered. 2009;100:246\u201350.","journal-title":"J Hered"},{"key":"519_CR34","first-page":"1970","volume":"28","author":"A Lang","year":"2000","unstructured":"Lang A, H\u00f6rler D, Baici A. The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol. 2000;28:1970\u20139.","journal-title":"J Rheumatol"},{"key":"519_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10238-011-0131-z","volume":"11","author":"L Zhang","year":"2011","unstructured":"Zhang L, Hu H, Tian F, Song H, Zhang Y. Enhancement of subchondral bone quality by alendronate administration for reduction of cartilage degeneration in the early phase of experimental osteoarthritis. Clin Exp Med. 2011;11:235\u201343.","journal-title":"Clin Exp Med"},{"key":"519_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/art.21789","volume":"54","author":"D Hunter","year":"2005","unstructured":"Hunter D, Zhang Y, Niu J, Goggins J, Amin S, LaValley MP, et al. Increase in bone marrow lesions associated with cartilage loss. A longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum. 2005;54:1529\u201335.","journal-title":"Arthritis Rheum"},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bone.2003.11.021","volume":"34","author":"JP Pelletier","year":"2004","unstructured":"Pelletier JP, Boileau C, Brunet J, Boily M, Lejeunesse D, Reboul P, et al. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and Cathepsin K. Bone. 2004;34:527\u201338.","journal-title":"Bone"},{"key":"519_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0174-173X(85)80021-2","volume":"5","author":"V Everts","year":"1985","unstructured":"Everts V, Beertsen W, Tigchelaar-Gutter W. The digestion of phagocytosed collagen is inhibited by the proteinase inhibitors leupeptin and E-64. Coll Relat Res. 1985;5:315\u201336.","journal-title":"Coll Relat Res"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/154405910408301011","volume":"83","author":"S Kamolmatyakul","year":"2004","unstructured":"Kamolmatyakul S, Chen W, Yang S, Abe Y, Moroi R, Ashique AM, et al. IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway. J Dent Res. 2004;83:791\u20136.","journal-title":"J Dent Res"},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbrc.2007.06.028","volume":"360","author":"A Danjo","year":"2007","unstructured":"Danjo A, Yamaza T, Kido MA, Shimohira D, Tsukuba T, Kagiya T, et al. Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation. Biochem Biophys Res Commun. 2007;360:199\u2013204.","journal-title":"Biochem Biophys Res Commun"},{"key":"519_CR41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1089\/hum.2005.16.1413","volume":"16","author":"A Hiraide","year":"2005","unstructured":"Hiraide A, Yokoo N, Xin K-Q, Okuda K, Mizukami H, Ozawa K, et al. Repair of articular cartilage defect by intra-articular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum Gene Ther. 2005;16:1413\u201321.","journal-title":"Hum Gene Ther"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0519-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0519-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0519-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0519-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:29:32Z","timestamp":1728923372000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0519-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0519-3","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,16]]},"assertion":[{"value":"15 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}